ASDSA Calls on States to Protect Patients from Counterfeit Neurotoxins
The Dermatology Digest
APRIL 12, 2024
Recent cases where possibly counterfeit neurotoxins in Illinois and Tennessee led to a cluster of illnesses resembling Botulism highlight the need to strengthen patient safety through increased oversight of medical care in all settings, according to the American Society for Dermatologic Surgery Association (ASDSA).
Let's personalize your content